Fischer, T.F.; Czerniak, A.S.; Weiß, T.; Zellmann, T.; Zielke, L.; Els-Heindl, S.; Beck-Sickinger, A.G.
Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment. Cancers 2021, 13, 3788.
https://doi.org/10.3390/cancers13153788
AMA Style
Fischer TF, Czerniak AS, Weiß T, Zellmann T, Zielke L, Els-Heindl S, Beck-Sickinger AG.
Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment. Cancers. 2021; 13(15):3788.
https://doi.org/10.3390/cancers13153788
Chicago/Turabian Style
Fischer, Tobias F., Anne S. Czerniak, Tina Weiß, Tristan Zellmann, Lina Zielke, Sylvia Els-Heindl, and Annette G. Beck-Sickinger.
2021. "Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment" Cancers 13, no. 15: 3788.
https://doi.org/10.3390/cancers13153788
APA Style
Fischer, T. F., Czerniak, A. S., Weiß, T., Zellmann, T., Zielke, L., Els-Heindl, S., & Beck-Sickinger, A. G.
(2021). Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment. Cancers, 13(15), 3788.
https://doi.org/10.3390/cancers13153788